-
AWS Adds Capabilities For Amazon Aurora And Amazon DynamoDB, Introduces Amazon Neptune
Bio-IT World Brief | Yesterday at AWS re:Invent, Amazon Web Services (AWS) announced new database capabilities for Amazon Aurora and Amazon DynamoDB, and introduced Amazon Neptune, a new fully managed graph database service.
Nov 30, 2017
-
A Virus Shortage? BlueBird Bio Buys A Factory To Make Its Own
Forbes | Amid a reported shortage of the disabled viruses used for gene therapies, BlueBird Bio has purchased a 125,000-square-foot facility in Durham, North Carolina, that it will use for manufacturing the lentiviral vectors used in its treatments.
Nov 29, 2017
-
AI Exposes Patterns For Faster Drug Discovery
Bio-IT World Contributed Commentary | Though the results are just starting to emerge, AI is showing positive traction in drug development. Machine learning in particular can help pharma recover the value of repurposed drugs by finding new therapeutic applications for them.
Nov 29, 2017
-
A Grim Future? Here Are the Numbers
In the Pipeline | Here's a bracing look at the state of the pharma business, especially regarding R&D costs and return on investment. And let me warn you - it's not a feel-good outlook.
Nov 28, 2017
-
750 Raspberry Pis Turned Into Supercomputer for Los Alamos National Laboratory
ExtremeTech | A new project at the Los Alamos National Laboratory's High Performance Computing Division seeks to make supercomputers more accessible with help from Raspberry Pi clusters.
Nov 28, 2017
-
Gene Therapy Hits A Peculiar Roadblock: A Virus Shortage
The New York Times | Revolutionary new treatments depend on tailor-made viruses, but laboratories cannot make them fast enough.
Nov 27, 2017
-
Three IT Tracks At Tri-Con Dig Deep Into Cloud, Data Commons, FAIR Data
Bio-IT World | The Molecular Medicine Tri-Conference will celebrate its 25th anniversary next February in San Francisco. Here are a few of the talks coming from the conference we’ve marked so far.
Nov 27, 2017
